當前位置：首頁 SCI期刊 SCIE期刊醫學中科院4區 JCRQ1 期刊介紹(非官網)

NanomedicineSCIE

國際簡稱：NANOMEDICINE-UK 參考譯名：納米醫學

中科院分區
4區
CiteScore分區
Q1
JCR分區
Q1

基本信息：: ISSN：1743-5889; E-ISSN：1748-6963; 是否OA：未開放; 是否預警：否; TOP期刊：否

出版信息：: 出版地區：ENGLAND; 出版商：Future Medicine Ltd.; 出版語言：English; 出版周期：Monthly; 出版年份：2006; 研究方向：醫學-納米科技

評價信息：: 影響因子：4.7; H-index：93; CiteScore指數：8.1; SJR指數：0.67; SNIP指數：0.562

發文數據：: Gold OA文章占比：8.87%; 研究類文章占比：70.00%; 年發文量：140; 自引率：0.0363...; 開源占比：0.1047; 出版撤稿占比：0; 出版國人文章占比：0.21; OA被引用占比：0.1158...

投稿咨詢加急見刊

英文簡介期刊介紹 CiteScore數據中科院SCI分區 JCR分區發文數據常見問題

英文簡介Nanomedicine期刊介紹

Medicine has developed throughout time but has remained forever concerned with the maintenance of health and thus the science of prevention and alleviation, and ultimately curing, of disease. To continue its development in new directions, medicine is now looking to nanomedicine, an emerging scientific specialty born from nanotechnology, which has grown up in the fields of engineering, physics, chemistry and biotechnology, and is now moving into medicine, with huge potential for expansion and development over the next decade and beyond.

As our knowledge of the human body continues to improve, nanotechnology will be developed to monitor, repair and control human biological systems at the molecular level. This will offer unique opportunities for developing new therapeutic approaches to diagnose, prevent, treat and eradicate life-threatening diseases and conditions (such as cancer and diabetes), as well as resolving pain and improving medical techniques (such as bone repair and surgical techniques), through various novel nanotechnological approaches.

Nanomedicine (ISSN 1743-5889) is a uniquely medicine-focused journal, addressing the important challenges and advances in medical nanoscale-structured material and devices, biotechnology devices and molecular machine systems and nanorobotics, delivering this essential information in concise, clear and attractive article formats. The journal is a valuable information source for all players in the field – academic, industrial and clinical researchers, pharmaceutical and biotechnology companies, regulatory authorities and others across the scientific community.

The nanomedicine field is still in its infancy, however, in the next few years there are likely to be further exciting developments across medical science, engineering, chemistry and physics. Diverse researchers working together under the nanomedicine umbrella will produce findings with potential medical uses: preventing, diagnosing and treating human diseases, as well as relieving pain. Nanomedicine will provide a critical overview of these advances as they unfold, helping to shape the future of medicine in this exciting era.

期刊簡介Nanomedicine期刊介紹

《Nanomedicine》自2006出版以來，是一本醫學優秀雜志。致力于發表原創科學研究結果，并為醫學各個領域的原創研究提供一個展示平臺，以促進醫學領域的的進步。該刊鼓勵先進的、清晰的闡述，從廣泛的視角提供當前感興趣的研究主題的新見解，或審查多年來某個重要領域的所有重要發展。該期刊特色在于及時報道醫學領域的最新進展和新發現新突破等。該刊近一年未被列入預警期刊名單，目前已被權威數據庫SCIE收錄，得到了廣泛的認可。

該期刊投稿重要關注點：

預計審稿時間：約6.0個月
醫學
BIOTECHNOLOGY & APPLIED MICROBIOLOGY
SCIE
中科院4區
非預警

Cite Score數據（2024年最新版）Nanomedicine Cite Score數據

CiteScore：8.1
SJR：0.67
SNIP：0.562

學科類別	分區	排名	百分位
大類：Social Sciences 小類：Development	Q1	26 / 306	91%
大類：Social Sciences 小類：Medicine (miscellaneous)	Q1	51 / 398	87%
大類：Social Sciences 小類：General Materials Science	Q1	99 / 463	78%
大類：Social Sciences 小類：Biomedical Engineering	Q1	66 / 303	78%
大類：Social Sciences 小類：Bioengineering	Q2	44 / 162	73%

CiteScore 是由Elsevier(愛思唯爾)推出的另一種評價期刊影響力的文獻計量指標。反映出一家期刊近期發表論文的年篇均引用次數。CiteScore以Scopus數據庫中收集的引文為基礎，針對的是前四年發表的論文的引文。CiteScore的意義在于，它可以為學術界提供一種新的、更全面、更客觀地評價期刊影響力的方法，而不僅僅是通過影響因子(IF)這一單一指標來評價。

歷年Cite Score趨勢圖

中科院SCI分區Nanomedicine 中科院分區

中科院 2023年12月升級版 綜述期刊：否 Top期刊：否

大類學科	分區	小類學科	分區
醫學	4區	BIOTECHNOLOGY & APPLIED MICROBIOLOGY 生物工程與應用微生物 NANOSCIENCE & NANOTECHNOLOGY 納米科技	3區 4區

中科院分區表 是以客觀數據為基礎，運用科學計量學方法對國際、國內學術期刊依據影響力進行等級劃分的期刊評價標準。它為我國科研、教育機構的管理人員、科研工作者提供了一份評價國際學術期刊影響力的參考數據，得到了全國各地高校、科研機構的廣泛認可。

中科院分區表 將所有期刊按照一定指標劃分為1區、2區、3區、4區四個層次，類似于“優、良、及格”等。最開始，這個分區只是為了方便圖書管理及圖書情報領域的研究和期刊評估。之后中科院分區逐步發展成為了一種評價學術期刊質量的重要工具。

歷年中科院分區趨勢圖

JCR分區Nanomedicine JCR分區

2023-2024 年最新版

按JIF指標學科分區	收錄子集	分區	排名	百分位
學科：BIOTECHNOLOGY & APPLIED MICROBIOLOGY	SCIE	Q1	29 / 174	83.6%
學科：NANOSCIENCE & NANOTECHNOLOGY	SCIE	Q2	55 / 140	61.1%

按JCI指標學科分區	收錄子集	分區	排名	百分位
學科：BIOTECHNOLOGY & APPLIED MICROBIOLOGY	SCIE	Q2	82 / 174	53.16%
學科：NANOSCIENCE & NANOTECHNOLOGY	SCIE	Q2	64 / 140	54.64%

JCR分區的優勢在于它可以幫助讀者對學術文獻質量進行評估。不同學科的文章引用量可能存在較大的差異，此時單獨依靠影響因子(IF)評價期刊的質量可能是存在一定問題的。因此，JCR將期刊按照學科門類和影響因子分為不同的分區，這樣讀者可以根據自己的研究領域和需求選擇合適的期刊。

歷年影響因子趨勢圖

發文數據

2023-2024 年國家/地區發文量統計

國家/地區數量
CHINA MAINLAND178
USA120
India78
Italy43
England32
Spain31
Egypt29
Iran26
Australia24
Brazil23

本刊中國學者近年發表論文

1、Smart nanostructures for targeted oxygen-producing photodynamic therapy of skin photoaging and potential mechanism
Author: Wang, Yun; Lu, Zhaopeng; Huang, Yuqi; Jia, Wenyu; Wang, Wandong; Zhang, Xin; Chen, Cheng; Li, Yizhi; Yang, Chunsheng; Jiang, Guan

Journal: NANOMEDICINE. 2023; Vol. 18, Issue 3, pp. 217-231. DOI: 10.2217/nnm-2022-0170
2、Preparation and evaluation of paclitaxel-loaded reactive oxygen species and glutathione redox-responsive poly(lactic-co-glycolic acid) nanoparticles for controlled release in tumor cells
Author: Wang, Siying; Han, Feng; Xie, Lanlan; Liu, Yanjie; Yang, Qilei; Zhao, Dongmei; Zhao, Xiuhua

Journal: NANOMEDICINE. 2023; Vol. 17, Issue 22, pp. 1627-1648. DOI: 10.2217/nnm-2022-0164
3、Nanomedicines in oral cancer: inspiration comes from extracellular vesicles and biomimetic nanoparticles
Author: Bai, Yu-Ting; Zhang, Xue-Qiong; Chen, Xiao-Jie; Zhou, Gang

Journal: NANOMEDICINE. 2023; Vol. , Issue , pp. -. DOI: 10.2217/nnm-2022-0142
4、Nanoparticle vaccine based on the envelope protein domain III of Japanese encephalitis virus elicits robust protective immune responses in mice
Author: Yao, Manman; Ren, Xujiao; Yin, Mengge; Chen, Huanchun; Li, Xiangmin; Qian, Ping

Journal: NANOMEDICINE. 2023; Vol. 18, Issue 1, pp. 5-18. DOI: 10.2217/nnm-2022-0298
5、Nanocarrier-based delivery of arsenic trioxide for hepatocellular carcinoma therapy
Author: Sun, Jiang; Cheng, Mengying; Ye, Tingxian; Li, Bin; Wei, Yinghui; Zheng, Hangsheng; Zheng, Hongyue; Zhou, Meiqi; Piao, Ji-Gang; Li, Fanzhu

Journal: NANOMEDICINE. 2023; Vol. 17, Issue 26, pp. 2037-2054. DOI: 10.2217/nnm-2022-0250
6、Synergistic antitumor effect of folate-targeted Pluronic (TM) F-127/poly(lactic acid) polymersomes for codelivery of doxorubicin and paclitaxel
Author: Wu, Tian Yi; Li, Zi Ling; Gong, Yan Chun; Xiong, Xiang Yuan

Journal: NANOMEDICINE. 2023; Vol. , Issue , pp. -. DOI: 10.2217/nnm-2022-0212
7、Polylactic-co-glycolic acid-based nanoparticles modified with peptides and other linkers cross the blood-brain barrier for targeted drug delivery
Author: Na, Yue; Zhang, Ning; Zhong, Xinyu; Gu, Jinlian; Yan, Chang; Yin, Shun; Lei, Xia; Zhao, Jihui; Geng, Fang

Journal: NANOMEDICINE. 2023; Vol. 18, Issue 2, pp. 125-143. DOI: 10.2217/nnm-2022-0287
8、Cascade biomimetic intelligent nanotheranostic agents for imaging-guided tumor synergistic therapy
Author: Fang, Zhengzou; Zhu, Ziyu; Zhuang, Zijian; Li, Zhangzuo; Yan, Cheng; Yang, Mengting; Chen, Qian; Li, Xinyuan; Gong, Aihua

Journal: NANOMEDICINE. 2023; Vol. 18, Issue 1, pp. 35-52. DOI: 10.2217/nnm-2022-0266